Symbol Name ID |
Alg13
asparagine-linked glycosylation 13 MGI:1914824 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Alg13em1Bayu/Y involves: C57BL/6J |
abnormal synaptic plasticity | J:275180 |
astrocytosis | J:275180 | |
environmentally induced seizures | J:275180 | |
increased susceptibility to pharmacologically induced seizures | J:275180 | |
increased susceptibility to xenobiotic induced morbidity/mortality | J:275180 | |
loss of hippocampal neurons | J:275180 | |
Alg13Gt(P035H04)Wrst/Y chimera involves: 129S6/SvEvTac * C57BL/6J |
abnormal developmental patterning | J:160967 |
cardia bifida | J:160967 | |
embryonic lethality | J:160967 | |
failure of initiation of embryo turning | J:160967 | |
Alg13Gt(P088H08)Wrst/Y chimera involves: 129S2/SvPas |
failure to gastrulate | J:160967 |
Alg13tm1a(KOMP)Wtsi/Alg13tm1a(KOMP)Wtsi C57BL/6N-Alg13tm1a(KOMP)Wtsi/Wtsi |
decreased bone mineral content | J:211773 |
decreased bone mineral density | J:211773 | |
decreased lean body mass | J:211773 | |
increased leukocyte cell number | J:211773 | |
increased total body fat amount | J:211773 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|